Review





Similar Products

human breast cancer tissue microarrays  (U.S Biomax Inc)
91
U.S Biomax Inc human breast cancer tissue microarrays
Human Breast Cancer Tissue Microarrays, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/high-density+breast+cancer+tissue+microarrays/High-density+breast+cancer+tissue+array+with+normal+tissue%2C+stage+and+grade+info%2C+104+cases%2F208+cores/pmc09249210-209-0-8
Average 91 stars, based on 1 article reviews
human breast cancer tissue microarrays - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
human breast cancer tissue microarray  (U.S Biomax Inc)
91
U.S Biomax Inc human breast cancer tissue microarray
A Graph showing GPR110 expression in stage1 ( n = 371), stage2 ( n = 571), and stage3 ( n = 90) of breast cancers using the database from METABRIC breast cancer databases. B Tissue <t>microarray</t> analysis of GPR110 expression in different stages of breast cancer (left) and the proportion is shown in the graph (right). C Graph showing GPR110 expression in grade1 ( n = 170), grade2 ( n = 770), and grade3 ( n = 952) of breast cancers using the database from METABRIC breast cancer databases. D Tissue microarray analysis of GPR110 expression in different grades of breast cancer (left) and the proportion in shown in the graph (right). E Kaplan–Meier survival analysis showed that high expression of GPR110 was associated with a poor survival rate of breast cancer patients obtained from the GEO database (GSE25085, GSE11121). F Kapan–Meier survival analysis of metastatic breast cancer patients (GSE45255, GSE7390). G GSEA of metastasis and cancer progression signature to GPR110 expression in breast cancer patients. H Schematic of GPR110/Gαs/RAS signaling axis mechanism in breast cancer. * p < 0.05, ** p < 0.001 and **** p < 0.0001; ns not significant; determined by two-tailed Student’s t test (95% confidence interval).
Human Breast Cancer Tissue Microarray, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/high-density+breast+cancer+tissue+microarrays/High-density+breast+cancer+tissue+array+with+normal+tissue%2C+stage+and+grade+info%2C+104+cases%2F208+cores/pmc09132940-227-0-9
Average 91 stars, based on 1 article reviews
human breast cancer tissue microarray - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
breast tissue microarray tma id br20832  (U.S Biomax Inc)
93
U.S Biomax Inc breast tissue microarray tma id br20832
A Graph showing GPR110 expression in stage1 ( n = 371), stage2 ( n = 571), and stage3 ( n = 90) of breast cancers using the database from METABRIC breast cancer databases. B Tissue <t>microarray</t> analysis of GPR110 expression in different stages of breast cancer (left) and the proportion is shown in the graph (right). C Graph showing GPR110 expression in grade1 ( n = 170), grade2 ( n = 770), and grade3 ( n = 952) of breast cancers using the database from METABRIC breast cancer databases. D Tissue microarray analysis of GPR110 expression in different grades of breast cancer (left) and the proportion in shown in the graph (right). E Kaplan–Meier survival analysis showed that high expression of GPR110 was associated with a poor survival rate of breast cancer patients obtained from the GEO database (GSE25085, GSE11121). F Kapan–Meier survival analysis of metastatic breast cancer patients (GSE45255, GSE7390). G GSEA of metastasis and cancer progression signature to GPR110 expression in breast cancer patients. H Schematic of GPR110/Gαs/RAS signaling axis mechanism in breast cancer. * p < 0.05, ** p < 0.001 and **** p < 0.0001; ns not significant; determined by two-tailed Student’s t test (95% confidence interval).
Breast Tissue Microarray Tma Id Br20832, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/high-density+breast+cancer+tissue+microarrays/pm34570844-93-5-18
Average 93 stars, based on 1 article reviews
breast tissue microarray tma id br20832 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
breast tumor tissue microarrays tmas  (U.S Biomax Inc)
91
U.S Biomax Inc breast tumor tissue microarrays tmas
A Graph showing GPR110 expression in stage1 ( n = 371), stage2 ( n = 571), and stage3 ( n = 90) of breast cancers using the database from METABRIC breast cancer databases. B Tissue <t>microarray</t> analysis of GPR110 expression in different stages of breast cancer (left) and the proportion is shown in the graph (right). C Graph showing GPR110 expression in grade1 ( n = 170), grade2 ( n = 770), and grade3 ( n = 952) of breast cancers using the database from METABRIC breast cancer databases. D Tissue microarray analysis of GPR110 expression in different grades of breast cancer (left) and the proportion in shown in the graph (right). E Kaplan–Meier survival analysis showed that high expression of GPR110 was associated with a poor survival rate of breast cancer patients obtained from the GEO database (GSE25085, GSE11121). F Kapan–Meier survival analysis of metastatic breast cancer patients (GSE45255, GSE7390). G GSEA of metastasis and cancer progression signature to GPR110 expression in breast cancer patients. H Schematic of GPR110/Gαs/RAS signaling axis mechanism in breast cancer. * p < 0.05, ** p < 0.001 and **** p < 0.0001; ns not significant; determined by two-tailed Student’s t test (95% confidence interval).
Breast Tumor Tissue Microarrays Tmas, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/high-density+breast+cancer+tissue+microarrays/High-density+breast+cancer+tissue+array+with+normal+tissue%2C+stage+and+grade+info%2C+104+cases%2F208+cores/pm31577845-57-0-8
Average 91 stars, based on 1 article reviews
breast tumor tissue microarrays tmas - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
immunohistochemistry breast cancer tissue microarrays  (U.S Biomax Inc)
91
U.S Biomax Inc immunohistochemistry breast cancer tissue microarrays
A Graph showing GPR110 expression in stage1 ( n = 371), stage2 ( n = 571), and stage3 ( n = 90) of breast cancers using the database from METABRIC breast cancer databases. B Tissue <t>microarray</t> analysis of GPR110 expression in different stages of breast cancer (left) and the proportion is shown in the graph (right). C Graph showing GPR110 expression in grade1 ( n = 170), grade2 ( n = 770), and grade3 ( n = 952) of breast cancers using the database from METABRIC breast cancer databases. D Tissue microarray analysis of GPR110 expression in different grades of breast cancer (left) and the proportion in shown in the graph (right). E Kaplan–Meier survival analysis showed that high expression of GPR110 was associated with a poor survival rate of breast cancer patients obtained from the GEO database (GSE25085, GSE11121). F Kapan–Meier survival analysis of metastatic breast cancer patients (GSE45255, GSE7390). G GSEA of metastasis and cancer progression signature to GPR110 expression in breast cancer patients. H Schematic of GPR110/Gαs/RAS signaling axis mechanism in breast cancer. * p < 0.05, ** p < 0.001 and **** p < 0.0001; ns not significant; determined by two-tailed Student’s t test (95% confidence interval).
Immunohistochemistry Breast Cancer Tissue Microarrays, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/high-density+breast+cancer+tissue+microarrays/pm28534508-255-3-11
Average 91 stars, based on 1 article reviews
immunohistochemistry breast cancer tissue microarrays - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
tissue microarray tma br20837  (U.S Biomax Inc)
91
U.S Biomax Inc tissue microarray tma br20837
A Graph showing GPR110 expression in stage1 ( n = 371), stage2 ( n = 571), and stage3 ( n = 90) of breast cancers using the database from METABRIC breast cancer databases. B Tissue <t>microarray</t> analysis of GPR110 expression in different stages of breast cancer (left) and the proportion is shown in the graph (right). C Graph showing GPR110 expression in grade1 ( n = 170), grade2 ( n = 770), and grade3 ( n = 952) of breast cancers using the database from METABRIC breast cancer databases. D Tissue microarray analysis of GPR110 expression in different grades of breast cancer (left) and the proportion in shown in the graph (right). E Kaplan–Meier survival analysis showed that high expression of GPR110 was associated with a poor survival rate of breast cancer patients obtained from the GEO database (GSE25085, GSE11121). F Kapan–Meier survival analysis of metastatic breast cancer patients (GSE45255, GSE7390). G GSEA of metastasis and cancer progression signature to GPR110 expression in breast cancer patients. H Schematic of GPR110/Gαs/RAS signaling axis mechanism in breast cancer. * p < 0.05, ** p < 0.001 and **** p < 0.0001; ns not significant; determined by two-tailed Student’s t test (95% confidence interval).
Tissue Microarray Tma Br20837, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/high-density+breast+cancer+tissue+microarrays/pmc05627411-82-0-12
Average 91 stars, based on 1 article reviews
tissue microarray tma br20837 - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
breast tissue microarray  (U.S Biomax Inc)
93
U.S Biomax Inc breast tissue microarray
A Graph showing GPR110 expression in stage1 ( n = 371), stage2 ( n = 571), and stage3 ( n = 90) of breast cancers using the database from METABRIC breast cancer databases. B Tissue <t>microarray</t> analysis of GPR110 expression in different stages of breast cancer (left) and the proportion is shown in the graph (right). C Graph showing GPR110 expression in grade1 ( n = 170), grade2 ( n = 770), and grade3 ( n = 952) of breast cancers using the database from METABRIC breast cancer databases. D Tissue microarray analysis of GPR110 expression in different grades of breast cancer (left) and the proportion in shown in the graph (right). E Kaplan–Meier survival analysis showed that high expression of GPR110 was associated with a poor survival rate of breast cancer patients obtained from the GEO database (GSE25085, GSE11121). F Kapan–Meier survival analysis of metastatic breast cancer patients (GSE45255, GSE7390). G GSEA of metastasis and cancer progression signature to GPR110 expression in breast cancer patients. H Schematic of GPR110/Gαs/RAS signaling axis mechanism in breast cancer. * p < 0.05, ** p < 0.001 and **** p < 0.0001; ns not significant; determined by two-tailed Student’s t test (95% confidence interval).
Breast Tissue Microarray, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/high-density+breast+cancer+tissue+microarrays/High-density+breast+cancer+tissue+array+with+normal+tissue%2C+stage+and+grade+info%2C+104+cases%2F208+cores/pm24965124-39-1-5
Average 93 stars, based on 1 article reviews
breast tissue microarray - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

Image Search Results


A Graph showing GPR110 expression in stage1 ( n = 371), stage2 ( n = 571), and stage3 ( n = 90) of breast cancers using the database from METABRIC breast cancer databases. B Tissue microarray analysis of GPR110 expression in different stages of breast cancer (left) and the proportion is shown in the graph (right). C Graph showing GPR110 expression in grade1 ( n = 170), grade2 ( n = 770), and grade3 ( n = 952) of breast cancers using the database from METABRIC breast cancer databases. D Tissue microarray analysis of GPR110 expression in different grades of breast cancer (left) and the proportion in shown in the graph (right). E Kaplan–Meier survival analysis showed that high expression of GPR110 was associated with a poor survival rate of breast cancer patients obtained from the GEO database (GSE25085, GSE11121). F Kapan–Meier survival analysis of metastatic breast cancer patients (GSE45255, GSE7390). G GSEA of metastasis and cancer progression signature to GPR110 expression in breast cancer patients. H Schematic of GPR110/Gαs/RAS signaling axis mechanism in breast cancer. * p < 0.05, ** p < 0.001 and **** p < 0.0001; ns not significant; determined by two-tailed Student’s t test (95% confidence interval).

Journal: Cell Death Discovery

Article Title: GPR110 promotes progression and metastasis of triple-negative breast cancer

doi: 10.1038/s41420-022-01053-x

Figure Lengend Snippet: A Graph showing GPR110 expression in stage1 ( n = 371), stage2 ( n = 571), and stage3 ( n = 90) of breast cancers using the database from METABRIC breast cancer databases. B Tissue microarray analysis of GPR110 expression in different stages of breast cancer (left) and the proportion is shown in the graph (right). C Graph showing GPR110 expression in grade1 ( n = 170), grade2 ( n = 770), and grade3 ( n = 952) of breast cancers using the database from METABRIC breast cancer databases. D Tissue microarray analysis of GPR110 expression in different grades of breast cancer (left) and the proportion in shown in the graph (right). E Kaplan–Meier survival analysis showed that high expression of GPR110 was associated with a poor survival rate of breast cancer patients obtained from the GEO database (GSE25085, GSE11121). F Kapan–Meier survival analysis of metastatic breast cancer patients (GSE45255, GSE7390). G GSEA of metastasis and cancer progression signature to GPR110 expression in breast cancer patients. H Schematic of GPR110/Gαs/RAS signaling axis mechanism in breast cancer. * p < 0.05, ** p < 0.001 and **** p < 0.0001; ns not significant; determined by two-tailed Student’s t test (95% confidence interval).

Article Snippet: Human breast cancer tissue microarray samples were obtained from US-Biomax (BR20838).

Techniques: Expressing, Microarray, Two Tailed Test